MiniMed intends to use a portion of the net proceeds from this offering for general corporate purposes. The remainder, if any, will be used to repay intercompany debt owed to Medtronic and as additional consideration to Medtronic for certain assets transferred to MiniMed in the separation.
Reported Earlier, Medtronic Subsidiary MiniMed Prices Initial Public Offering Of 28M Common Shares At $20.00 Each, Set To Trade On Nasdaq Under Symbol "MMED"
Login to comment